Consensus recommendations for severe aplastic anemia.
作者信息
Scheinberg Phillip, Kulasekararaj Austin G
机构信息
Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil.
Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London and King's College London, London, United Kingdom.
出版信息
Blood Adv. 2024 Nov 12;8(21):5719-5720. doi: 10.1182/bloodadvances.2024013529.
Abstract
摘要
相似文献
1
Consensus recommendations for severe aplastic anemia.重型再生障碍性贫血的共识性推荐意见。
Blood Adv. 2024 Nov 12;8(21):5719-5720. doi: 10.1182/bloodadvances.2024013529.
2
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.改良 Delphi 法-panel 共识推荐的再生障碍性贫血严重程度的管理建议。
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
3
Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.儿童重型再生障碍性贫血的诊断流程：北美儿童再生障碍性贫血联盟共识。
Am J Hematol. 2021 Nov 1;96(11):1491-1504. doi: 10.1002/ajh.26310. Epub 2021 Aug 20.
4
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.重型再生障碍性贫血：异基因骨髓移植作为一线治疗。
Blood Adv. 2018 Aug 14;2(15):2020-2028. doi: 10.1182/bloodadvances.2018021162.
5
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比，HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
6
Efficacy of hematopoietic stem cell transplantation in the treatment of children with non-severe aplastic anemia.造血干细胞移植治疗非重型再生障碍性贫血患儿的疗效
Pediatr Transplant. 2022 Nov;26(7):e14340. doi: 10.1111/petr.14340. Epub 2022 Jun 23.
7
Differences in the Differentiation Potential and Relative Levels of Gene Expression in the Bone Marrow-Derived Fibroblast Colony-Forming Units in Patients during the Onset of Aplastic Anemia Depending on the Disease Severity.再生障碍性贫血发病期间，根据疾病严重程度，患者骨髓来源的成纤维细胞集落形成单位在分化潜能和基因表达相对水平上的差异。
Bull Exp Biol Med. 2023 Feb;174(4):538-543. doi: 10.1007/s10517-023-05744-y. Epub 2023 Mar 11.
8
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.比较艾曲波帕联合免疫抑制治疗重型再生障碍性贫血和极重型再生障碍性贫血的疗效：真实世界数据和证据。
Ann Hematol. 2024 Sep;103(9):3483-3491. doi: 10.1007/s00277-024-05910-w. Epub 2024 Aug 1.
9
Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia.移植前血小板难治性和替代供体与重型再生障碍性贫血造血干细胞移植后巨细胞病毒视网膜炎相关。
Front Cell Infect Microbiol. 2022 Mar 15;12:870296. doi: 10.3389/fcimb.2022.870296. eCollection 2022.
10
Proposed protocol for treatment of severe periodontitis without platelet transfusion in patients with aplastic anemia: a case report.拟议的再生障碍性贫血伴血小板减少症患者不进行血小板输注治疗重度牙周炎的方案：一例报告。
J Med Case Rep. 2021 Dec 10;15(1):581. doi: 10.1186/s13256-021-03170-0.
引用本文的文献
1
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.造血细胞移植和嵌合抗原受体T细胞疗法治疗血液系统疾病、实体瘤及免疫紊乱的适应证：2025年欧洲血液与骨髓移植学会实践建议
Bone Marrow Transplant. 2025 Sep 9. doi: 10.1038/s41409-025-02701-3.
本文引用的文献
1
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.改良 Delphi 法-panel 共识推荐的再生障碍性贫血严重程度的管理建议。
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
2
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.重型再生障碍性贫血的替代供体移植：SAAWP-EBMT的一项比较研究
Blood. 2024 Jul 18;144(3):323-333. doi: 10.1182/blood.2024024173.
3
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.成人再生障碍性贫血诊断与治疗指南：英国血液学学会指南。
Br J Haematol. 2024 Mar;204(3):784-804. doi: 10.1111/bjh.19236. Epub 2024 Jan 21.
4
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.异基因造血干细胞移植联合移植后环磷酰胺治疗获得性重型再生障碍性贫血。
Blood. 2023 Jun 22;141(25):3031-3038. doi: 10.1182/blood.2023020435.
5
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.在严重再生障碍性贫血中进行基因检测对造血细胞移植的结果至关重要。
Blood. 2022 Aug 25;140(8):909-921. doi: 10.1182/blood.2022016508.
6
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.依鲁替尼联合免疫抑制治疗重型再生障碍性贫血。
N Engl J Med. 2022 Jan 6;386(1):11-23. doi: 10.1056/NEJMoa2109965.
7
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.获得性严重再生障碍性贫血：20 世纪和 21 世纪的医学治疗进展。
Br J Haematol. 2021 Sep;194(6):954-969. doi: 10.1111/bjh.17403. Epub 2021 Apr 14.
8
Aplastic Anemia.再生障碍性贫血
N Engl J Med. 2018 Oct 25;379(17):1643-1656. doi: 10.1056/NEJMra1413485.
9
How I treat acquired aplastic anemia.我如何治疗获得性再生障碍性贫血。
Blood. 2017 Mar 16;129(11):1428-1436. doi: 10.1182/blood-2016-08-693481. Epub 2017 Jan 17.
10
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.再生障碍性贫血中的体细胞突变与克隆性造血
N Engl J Med. 2015 Jul 2;373(1):35-47. doi: 10.1056/NEJMoa1414799.
Zotero 插件